Aging and antihypertensive medication-related complications in the chronic kidney disease patient
- 1 September 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Nephrology and Hypertension
- Vol. 20 (5), 449-456
- https://doi.org/10.1097/mnh.0b013e32834902ad
Abstract
Purpose of review We have reviewed the recent literature to describe the potential medication errors and adverse drug events (ADEs) associated with antihypertensives among older adults with chronic kidney disease (CKD). Recent findings Overall, few studies have been published describing ADEs in older adults with CKD. Several examined hyperkalemia associated with angiotensin-converting enzyme (ACE)-inhibitor/angiotensin II receptor blocker (ARB), diuretic (potassium-sparing), and β-blocker use. Additional studies described acute kidney injury (AKI) most commonly with ACE-inhibitor/ARB therapy. Finally, orthostatic hypotension was evaluated in those taking ACE-inhibitor/ARB, β-blocker, or calcium-channel blocker therapy. In the absence of robust literature examining these events in this understudied population, one must consider age-related antihypertensive pharmacokinetic/pharmacodynamic profiles concomitantly with the patient's comorbidities and other medications in order to minimize the risk for potential medication errors, drug–drug interactions, and ADEs. Summary Some of the most common ADEs associated with antihypertensive use in older adults with CKD include hyperkalemia, AKI, and orthostatic hypotension. Diligent monitoring of laboratory data, vital signs, and potential drug–drug interactions may mitigate serious ADEs caused by antihypertensives in this high-risk patient population.Keywords
This publication has 37 references indexed in Scilit:
- The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysisCMAJ : Canadian Medical Association Journal, 2011
- The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockersCMAJ : Canadian Medical Association Journal, 2011
- Predictors of Hyperkalemia Risk following Hypertension Control with Aldosterone BlockadeAmerican Journal of Nephrology, 2009
- Is there a role for direct renin inhibitors in chronic kidney disease?Current Opinion in Nephrology and Hypertension, 2009
- Hyperkalemia Risk in Chronic Kidney DiseaseHypertension, 2009
- Association of Antihypertensive Therapy and Diastolic Hypotension in Chronic Kidney DiseaseHypertension, 2007
- Pharmacokinetic-Pharmacodynamic Crisis in the ElderlyClinical Journal of Sport Medicine, 2007
- Postural Blood Pressure Changes and Orthostatic Hypotension in the Elderly PatientDrugs & Aging, 2005
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Calcium-Antagonist DrugsThe New England Journal of Medicine, 1999